End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,384 KRW | +9.75% | -22.42% | +134.97% |
2022 | StemLab Inc. announced that it has received KRW 1.5000006 billion in funding | CI |
2022 | StemLab Inc. announced that it expects to receive KRW 1.5000006 billion in funding | CI |
Chart calendar SL Therapeutics, Inc.
Upcoming events on SL Therapeutics, Inc.
No events available
Past events on SL Therapeutics, Inc.
2024-05-10 01:00 | Investor Meeting |
2024-03-20 | Q4 2023 Earnings Release |
2023-10-19 01:00 | Investor Meeting |
2023-05-25 03:00 | Investor Meeting |
2024-07-11 02:00 | BONESUPPORT HOLDING AB: Q2 2024 Earnings Release |
2024-07-15 | SWEDISH ORPHAN BIOVITRUM AB: Q2 2024 Earnings Release |
2024-07-22 | BIOGEN INC.: Q2 2024 Earnings Release (Projected) |
2024-07-23 02:00 | BIOGAIA AB: Q2 2024 Earnings Release |
2024-07-23 | SAMSUNG BIOLOGICS CO.,LTD.: Q2 2024 Earnings Release (Projected) |
2024-07-24 | PHARMA MAR, S.A.: Q2 2024 Earnings Release (Projected) |
2024-07-24 | GRIFOLS, S.A.: Q2 2024 Earnings Release (Projected) |
2024-07-25 01:00 | UCB: Q2 2024 Earnings Release |
2024-07-25 | SK BIOSCIENCE CO.,LTD.: Q2 2024 Earnings Release (Projected) |
2024-07-29 | BIOMARIN PHARMACEUTICAL INC.: Q2 2024 Earnings Release (Projected) |
Past sector events for SL Therapeutics, Inc.
2024-05-23 05:43 | CONCORD BIOTECH LIMITED: Q4 2024 Earnings Release |
2024-05-14 11:35 | GRIFOLS, S.A.: Q1 2024 Earnings Release |
2024-05-13 | NATURECELL CO.,LTD.: Q1 2024 Earnings Release |
2024-05-09 | PHARMARESEARCH CO., LTD.: Q1 2024 Earnings Release |
2024-05-09 | MEDY-TOX INC.: Q1 2024 Earnings Release |
2024-05-09 16:05 | AVIDITY BIOSCIENCES, INC.: Q1 2024 Earnings Release |
2024-05-09 16:05 | ADMA BIOLOGICS, INC.: Q1 2024 Earnings Release |
2024-05-09 02:30 | NXERA PHARMA CO., LTD.: Q1 2024 Earnings Release |
2024-05-08 | HUGEL, INC.: Q1 2024 Earnings Release |
2024-05-08 16:16 | CATALYST PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
- Stock Market
- Equities
- A258540 Stock
- Calendar SL Therapeutics, Inc.